July 23, 2024CorporateMicroVention Announces Release of CLinical EValuation of WEB™ 17 Device in Intracranial Aneurysms (CLEVER): One Year Effectiveness Results for Ruptured and Unruptured AneurysmsMicroVention is Also Celebrating the Five-Year Anniversary of its WEB™ Aneurysm Embolization System with more than 10,000 Units Sold in the United States
July 11, 2024FinancialNotice Regarding Disposal of Treasury Shares as Restricted Stock Remuneration (PDF 142.31 KB)
July 11, 2024FinancialNotice Concerning the Issuance of Stock Options (Share Warrants) (PDF 114.67 KB)
Investors Japanese Financial Results for the First Quarter of the Fiscal Year Ending 3/2025 Aug 8, 2024 Stock Quote Prime Market of TSE: Last Trade JPY Change JPY (%) Volume View Chart Top Management Message Hikaru Samejima Chief Executive Officer GS26: 5-Year Growth strategy 2022 - 2026 Terumo Report Sustainability What's New July 11, 2024 Notice Regarding Disposal of Treasury Shares as Restricted Stock Remuneration (PDF 142.31 KB) July 11, 2024 Notice Concerning the Issuance of Stock Options (Share Warrants) (PDF 114.67 KB) May 15, 2024 Audio webcast regarding Financial Results for FYE 3/2024 May 14, 2024 Presentation regarding Financial Results for FYE 3/2024 March 11, 2024 Notice Concerning the Status and Completion of the Acquisition of Own Shares and Cancellation of Treasury Stock (PDF 130.35 KB) View all Business Overview Introduction to the businesses operated by the Terumo Group /business Technology Introduction to Terumo's research and development activities and production system /technology
July 11, 2024 Notice Regarding Disposal of Treasury Shares as Restricted Stock Remuneration (PDF 142.31 KB)
March 11, 2024 Notice Concerning the Status and Completion of the Acquisition of Own Shares and Cancellation of Treasury Stock (PDF 130.35 KB)